This topic contains a solution. Click here to go to the answer

Author Question: If large, dominant firms tend to be more successful and last longer than small, non-dominant firms, ... (Read 164 times)

LCritchfi

  • Hero Member
  • *****
  • Posts: 519
If large, dominant firms tend to be more successful and last longer than small, non-dominant firms, it would be because:
 A) the large firm can dictate what it wants to consumers and to its suppliers.
  B) the large, dominant firm is able to offer more products at lower prices.
  C) the large, dominant firm has an advantage in its costs or in being able to meet customer wants.
  D) the small firm is a risk-taker and typically is not around for long.
  E) the small firm can never compete with the large firm.

Question 2

If entry into an industry was very easy, the four firm concentration ratio would not be a very useful index of the competitiveness in that industry
 a. True
  b. False
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kbennett34

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

C

Answer to Question 2

True





 

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

The training of an anesthesiologist typically requires four years of college, 4 years of medical school, 1 year of internship, and 3 years of residency.

Did you know?

Only one in 10 cancer deaths is caused by the primary tumor. The vast majority of cancer mortality is caused by cells breaking away from the main tumor and metastasizing to other parts of the body, such as the brain, bones, or liver.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library